We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a provider of on-demand and off-the-shelf European reimbursement analysis and strategy for industry and investment companies

News and blog posts

Stay up-to-date about developments of reimbursement systems in Europe

11 Apr 2018
Eight reimbursement reports with the total size of 882 pages cover the most common radiotherapy modalities including brachytherapy, 3D conformal radiation therapy, stereotactic radiosurgery, stereotactic body radiation therapy, intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), image-guided radiotherapy, proton therapy. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 12 EU countries including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

24

May 2018

In mid-May 2018, the Andalusian Agency for Health Technology Evaluation, AETSA, has published a structured summary on 18F-FDG PET in the early diagnosis of degenerative diseases of the central nervous system.

23

May 2018

On the 26th of April of 2018, the Federal Joint Committee (G-BA) has commissioned to the Institute for Quality and Efficiency in Health Care (IQWiG) to provide a rapid report regarding the current state of medical knowledge on synchronous balneophototherapy in atopic eczema. The identified results of the current state of medical knowledge would form the basis for the further G-BA’s assessment of adequacy, appropriateness and economic benefits of the researched method.

22

May 2018

Flash Glucose Monitoring (FGM) is covered care for four groups of diabetic patients who are already eligible for reimbursement of real-time continuous glucose monitoring (RTCGM). This is stated in the 'Flash Glucose Monitoring' assesement of the Dutch National Health Care Institute

21

May 2018

NHS Digital has published experimental statistics on patients that have had a procedure for urogynaecological prolapse or stress urinary incontinence including those where mesh, tape or their equivalents have been used

About us

We are a group of enthusiasts who are passionate about the areas of health policy, evidence generation, reimbursement and funding for medical technologies. We have turned our passion into a career. More specifically, we develop insights which help our customers optimize their business decisions

Originally established in Stockholm, the company has a presence in six European countries

The founder of company is Oleg Borisenko, one of the leading experts on European market access for medical devices. With more than 12 years of experience in the field, Oleg has led several hundred of projects. These include reimbursement analyses and strategies, value dossiers, health economic models and evidence generation strategies

Our team consists of twelve clinical coders and market analysts, including seven medical doctors and one pharmacist. Three of our members have PhD degrees in different areas of clinical and public health science

Our unique proposition is Pan-European reimbursement mapping and strategy projects for the Med Tech and IVD industries. To match the requirements and budget of our various customers, we approach their needs differently: from low-cost off-the-shelf reimbursement reports for dozens of medical technologies to full scale reimbursement and evidence generation projects

We provide analyses for 14 European countries

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • Transcatheter aortic valve implantation (TAVI) 
  • Eight minimally invasive and transcatheter mitral valve repair and replacement technologies
  • Group of peripheral vascular arterial interventions (angioplasty, angioplasty using drug-eluting balloon, stenting using bare metal and drug-eluting stents, atherectomy, periperal IVUS)
  • Robotic surgery interventions
  • Peripheral venous interventions for deep vein thrombosis and venous insufficiency
  • Coronary percutaneous revascularization (angioplasty using plain and drug-coated balloon, bare metal and drug-eluting stents, mechanical thrombectomy, percutaneous atherectomy)
  • Coronary percutaneous imaging procedures (angiography, IVUS, FFR, OCT)
  • Mechanical thrombectomy for stroke
  • Ablation of heart tissue for atrial fibrillation
  • Radiotherapy procedures (all types)

Ongoing reports:

  • Procedures on spine for intervertebral disc prolapse, vertebra fracture
  • Interventional procedure for gastro-esophageal reflux disease
  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Surgical and endovascular treatment of brain aneurysm
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators